Evidence map›Paper›PMID 34791627›Full record

ArticleIn vitro cellular & developmental biology. Animal2021

Epithelial mesenchymal transition regulator TWIST1 transcription factor stimulates glucose uptake through upregulation of GLUT1, GLUT3, and GLUT12 in vitro.

Suray Pehlivanoglu, Ozge Burcu Sahan, Sebnem Pehlivanoglu, Kadriye Aktas Kont

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. The glucose transporter GLUT12, a new actor in obesity and cancer.Journal of physiology and biochemistry · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Suray PehlivanogluDepartment of Molecular Biology and Genetics, Faculty of Science, Necmettin Erbakan University, Konya, Turkey. spehlivanoglu@erbakan.edu.tr.ORCID http://orcid.org/0000-0001-7422-2974
Ozge Burcu SahanCenter for Stem Cells Research and Development, Hacettepe University, Ankara, Turkey.
Sebnem PehlivanogluAziz Sancar Research Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Kadriye Aktas KontDepartment of Molecular Biology and Genetics, Faculty of Science, Necmettin Erbakan University, Konya, Turkey.
Necmettin Erbakan University · TRHacettepe University · TR

Funding

Scientific Research Projects Coordination Unit of Necmettin Erbakan University 161315002
6 · The paper itself

Abstract

TWIST1 is a major regulator of epithelial mesenchymal transition process, essential in cancer metastasis. Cancer cells increase glucose uptake capabilities to meet their high energy requirements. In this study, we explored the potential role of TWIST1 on glucose transport into the 293T cells in an insulin-dependent and insulin-independent manner. For this purpose, the ectopic expression of TWIST1 was successfully performed by electroporation. The altered mRNA expressions of GLUT-1, -3, -4, and -12, insulin receptor (InsR), and insulin receptor substrate (IRS)-1 and -2 were assessed in control and TWIST1-overexpressing cells. Glucose uptake rates of the cells were evaluated by fluorometric glucose uptake assay. Our findings showed that the transcriptional expression levels of GLUT-1, -3, and -12 genes were significantly upregulated by TWIST1. However, TWIST1 did not alter the mRNA and protein expressions of the InsR, its substrates (IRS-1 and -2), and GLUT-4 genes in 293T cells which are main factors for insulin-stimulated glucose uptake pathway. Also, the glucose transport activities were significantly increased in TWIST1-overexpressing cells compared to controls due to fetal bovine serum (FBS) stimulation, but there was a slight non-significant difference in insulin stimulation. Thus, our data suggest that TWIST1 could promote glucose uptake independently of insulin and is possible to be evaluated as a metabolic marker in cancer. Further investigations are needed to clarify the precise molecular mechanisms underlying the cells' glucose uptake and consumption during tumorigenesis.

Indexed as

Epithelial-Mesenchymal TransitionGene Expression RegulationGlucoseGlucose Transporter Type 1Glucose Transporter Type 3Glucose Transport Proteins, FacilitativeHEK293 CellsHumansInsulinNuclear ProteinsTwist-Related Protein 1GlucoseGlucose Transporter Type 1Glucose Transporter Type 3Glucose Transport Proteins, FacilitativeInsulinNuclear ProteinsSLC2A12 protein, humanSLC2A1 protein, humanSLC2A3 protein, humanTWIST1 protein, humanTwist-Related Protein 1Glucose transportersGlucose uptakeInsulinTWIST1

Identifiers

PMID34791627
OpenAlexW3212596569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.